A phase IIb trial to evaluate KB 001-A for the prevention of ventilator-associated pneumonia

Trial Profile

A phase IIb trial to evaluate KB 001-A for the prevention of ventilator-associated pneumonia

Planning
Phase of Trial: Phase II

Latest Information Update: 07 Aug 2017

At a glance

  • Drugs KB 001-A (Primary)
  • Indications Pneumonia
  • Focus Therapeutic Use
  • Most Recent Events

    • 07 Aug 2017 According to Humanigen media release, KaloBios Pharmaceuticals changed its name to Humanigen.
    • 17 Jun 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top